INNO, A.; BOGINA, G.; SETTANNI, G.; SALGARELLO, M.; FOTI, G.; POMARI, C.; PICECE, V.; GORI, S. First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. Drug Target Insights, [S. l.], v. 17, n. 1, p. 110–113, 2023. DOI: 10.33393/dti.2023.2626. Disponível em: https://journals.aboutscience.eu/index.php/dti/article/view/2626. Acesso em: 23 nov. 2024.